|
|
SPOT ON
|
|
Drug companies: who belongs to whom?
|
|
|
THERAPIES FROM A CRITICAL VIEWPOINT
|
|
Breast cancer: the value of systemic adjuvant therapy
Vitamin D (e.g. VIGANTOLETTEN) and calcium for osteoporosis in the elderly
|
|
|
BEWARE MISINFORMATION
|
|
Levodopa-benserazid combination RESTEX: according to SPC now with fewer side effects?
|
|
|
a-t READERS' QUESTIONS AND COMMENTS
|
|
Animadversion on antidepressants: what to do? |
|
Bevacizumab (AVASTIN): inhibitior of angiogenesis for colorectal cancer
|
|
|
IN BRIEF
|
|
Radical prostatectomy reduces mortality in early prostate cancer
Cox-2-inhibitor parecoxib (DYNASTAT) off the market in Switzerland
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Skin necrosis after injection of glatiramer acetate (COPAXONE)
|
|
|
SIDE EFFECTS
|
|
Bisphosphonates: non-traumatic fractures with protracted healing with alendronat (FOSAMAX)
Exophtalmos with glitazones
|
|